title: Reversal of atherosclerosis with apolipoprotein A1: back to basics.
authors.affiliation: Department of Vascular Medicine, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
authors.forename: Loek P
authors.initials: LP
authors.lastname: Smits
authors.affiliation: Department of Vascular Medicine, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.
authors.forename: Ruud S
authors.initials: RS
authors.lastname: Kootte
authors.affiliation: Department of Vascular Medicine, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. Electronic address: e.s.stroes@amc.uva.nl.
authors.forename: Erik S
authors.initials: ES
authors.lastname: Stroes
mesh_terms: D000818:Animals; D016632:Apolipoprotein A-I / Q000737:chemistry* / Q000494:pharmacology; D050197:Atherosclerosis / Q000188:drug therapy*; D032701:Biomimetics; D006801:Humans; D008075:Lipoproteins, HDL / Q000097:blood*; D008297:Male; D010743:Phospholipids / Q000737:chemistry* / Q000494:pharmacology; D011994:Recombinant Proteins / Q000494:pharmacology*
chemical_list: D016632:Apolipoprotein A-I; C000591544:CER-001; D008075:Lipoproteins, HDL; D010743:Phospholipids; D011994:Recombinant Proteins
keywords: Apolipoprotein A-1 (apoA-1); Atherosclerosis; Cardiovascular disease (CVD); High-density lipoprotein (HDL); Reverse cholesterol transport